Johnson, Paul D. R.

Reduced Vancomycin Susceptibility in Staphylococcus aureus , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

Howden, B. P., Davies, J. K., Johnson, P. D. R., Stinear, T. P., & Grayson, M. L. (2010) · Clinical Microbiology Reviews

Antimicrobial Resistance in StaphylococcusAntibiotic Resistance in Bacteria

Cited by 962

Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis

Stinear, T. P., Seemann, T., Harrison, P. F., Jenkin, G. A., Davies, J. K., Johnson, P. D. R., Abdellah, Z., Arrowsmith, C., Chillingworth, T., Churcher, C., et al. (2008) · Genome Research

Tuberculosis Research and EpidemiologyMycobacterium research and diagnosis

Cited by 570

Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations

Holmes, N. E., Turnidge, J. D., Munckhof, W. J., Robinson, J. O., Korman, T. M., O’Sullivan, M. V. N., Anderson, T. L., Roberts, S. A., Gao, W., Christiansen, K. J., et al. (2011) · The Journal of Infectious Diseases

Antimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and Efficacy

Cited by 228